Gingold Julian A, Kucherov Alexander, Wu Haotian, Fazzari Melissa, Lieman Harry, Ball G David, Doody Kevin, Jindal Sangita
Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York; Montefiore's Institute for Reproductive Medicine and Health, Hartsdale, New York.
Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York; Montefiore's Institute for Reproductive Medicine and Health, Hartsdale, New York; Illume Fertility, Norwalk, Connecticut.
Fertil Steril. 2025 Jan;123(1):50-60. doi: 10.1016/j.fertnstert.2024.08.315. Epub 2024 Aug 10.
To evaluate the impact of preimplantation genetic testing for aneuploidy (PGT-A) on first transfer live birth rate (LBR) and cumulative LBR (CLBR) in donor oocyte in vitro fertilization (IVF) cycles.
Retrospective cohort study of the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database.
Fertility centers reporting to Society for Assisted Reproductive Technology.
PATIENT(S): A total of 11,348 fresh and 7,214 frozen-thawed donor oocyte IVF cycles were analyzed.
INTERVENTION(S): The first reported donor stimulation cycle per patient between January 1, 2014, and December 31, 2015, and all linked embryo transfer cycles between January 1, 2014, and December 31, 2016, were included in the study.
MAIN OUTCOME MEASURE(S): Live birth rate was compared for patients using fresh and frozen-thawed donor oocytes, with or without PGT-A. Logistic regression models were adjusted for age, body mass index, gravidity, infertility etiology, and prior IVF cycles.
RESULT(S): Among patients who had blastocysts available for transfer or PGT-A, the use of PGT-A was associated with a decreased first transfer LBR (46.9 vs. 53.2%) and CLBR (58.4 vs. 66.6%) in fresh oocyte donor cycles compared with no PGT-A. Live birth rate in frozen-thawed oocyte donor cycles with PGT-A were nominally higher than those without PGT-A (48.3% vs. 40.5%) but were not statistically significant in multivariable logistic regression models. Early pregnancy loss was not significantly different with and without PGT-A. Multiple gestation, preterm birth, and low birth weight infants were all reduced with the addition of PGT-A in fresh donor oocyte cycles, although these outcomes were not significantly different when comparing single embryo transfers in fresh oocyte cycles and also not significantly different among frozen-thawed donor oocyte cycles.
CONCLUSION(S): Preimplantation genetic testing for aneuploidy in fresh oocyte donor cycles was associated with decreased LBR and CLBR, whereas effects on frozen-thawed oocyte donor cycles were clinically negligible. Obstetric benefits associated with PGT-A in fresh donor cycles appear linked to increased single embryo transfer.
评估胚胎植入前非整倍体基因检测(PGT-A)对供卵体外受精(IVF)周期首次移植活产率(LBR)和累积活产率(CLBR)的影响。
对辅助生殖技术协会诊所结果报告系统数据库进行回顾性队列研究。
向辅助生殖技术协会报告的生育中心。
共分析了11348个新鲜和7214个冻融供卵IVF周期。
纳入2014年1月1日至2015年12月31日期间每位患者首次报告的供体刺激周期,以及2014年1月1日至2016年12月31日期间所有相关的胚胎移植周期。
比较使用新鲜和冻融供卵且进行或未进行PGT-A的患者的活产率。逻辑回归模型根据年龄、体重指数、妊娠次数、不孕病因和既往IVF周期进行了调整。
在有可用于移植的囊胚或进行了PGT-A的患者中,与未进行PGT-A相比,在新鲜卵母细胞供体周期中使用PGT-A与首次移植LBR(46.9%对53.2%)和CLBR(58.4%对66.6%)降低相关。进行PGT-A的冻融卵母细胞供体周期的活产率名义上高于未进行PGT-A的周期(48.3%对40.5%),但在多变量逻辑回归模型中无统计学意义。有无PGT-A时早期妊娠丢失无显著差异。在新鲜供卵周期中添加PGT-A后,多胎妊娠、早产和低体重儿均减少,尽管在比较新鲜卵母细胞周期中的单胚胎移植时这些结局无显著差异,且在冻融供卵周期中也无显著差异。
新鲜卵母细胞供体周期中的胚胎植入前非整倍体基因检测与LBR和CLBR降低相关,而对冻融卵母细胞供体周期的影响在临床上可忽略不计。新鲜供体周期中与PGT-A相关的产科益处似乎与单胚胎移植增加有关。